Spotlight on Uncontrolled Hypertension: Assessing the Shift Towards Personalised Medicine – Part 1
Overview
The programme provides an in-depth exploration of the latest strategies for managing uncontrolled hypertension, guided by recent recommendation from the ESC, ESH and KDIGO. It will examine different approaches to blood pressure control and evaluate the impact of guidance summaries such as the recent MASTERplan document, published in 2024.
The importance of accounting for cardiovascular (CV) risk and selecting appropriate treatment, will hence be a central theme throughout. Join Dr Jordana Cohen (Penn Medicine Hospital, Philadelphia, US) and Prof Kazem Rahimi (Oxford University Hospitals NHS Trust, Oxford, UK) in this live webinar as they reflect on the growing evidence base around uncontrolled hypertension and its impact on long-term CV and renal outcomes.
Aimed at a broad spectrum of healthcare professionals, this activity will provide participants with: a comprehensive understanding of the latest guidelines, the ability to assess CV risk and an understanding of the underlying pathophysiology of uncontrolled hypertension.
Learning Objectives
- Understand and reflect on recent guideline recommendations for managing uncontrolled hypertension
- Assess the cardiovascular risks associated with uncontrolled hypertension
- Discuss the pathophysiology of resistant and uncontrolled hypertension with a focus on aldosterone's role
Target Audience
- Cardiologists
- Hypertension Specialist
- Nephrologists
- Primary Care Physicians
- Pharmacists
- Healthcare Professionals